← Open Payments lookup

PETAGAYE REYES: Open Payments

NPI 1508563479 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,158 in 78 payments from 8 companies in 2025. Trend: 2023 $233 · 2024 $1,235 · 2025 $2,158

Food & beverage: $2,158
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.19$548
E.R. Squibb & Sons, L.L.C.10$522
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)17$406
ABBVIE INC.25$397
Alkermes, Inc.2$146
Janssen Pharmaceuticals, Inc3$84
Vanda Pharmaceuticals Inc.1$36
Teva Pharmaceuticals USA, Inc.1$18

Products named: COBENFY, CAPLYTA, VRAYLAR, REXULTI, ABILIFY ASIMTUFII, ABILIFY MAINTENA, LYBALVI, SPRAVATO.

Industry payments across PA — which companies pay providers there.